Holen Sie sich die Stockscreener-App
0.8798
10.44%
-0.1026
Handel nachbörslich:
.82
-0.0598
-6.80%
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
InspireMD Q2 revenue holds at $1.8 million - grafa.com
InspireMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
InspireMD Releases Q2 2026 Financial Results - AlphaStreet
Earnings call transcript: InspireMD Q2 2026 revenue miss weighs on shares - Investing.com
InspireMD Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K InspireMD Inc For: 17 August By Investing.com - Investing.com UK
InspireMD reports Q2 2026 revenue $1.77M, net loss $14.3M; cash & marketable securities $30.4M - TradingView
InspireMD Reports $1.77 Million Q2 Revenue and $14.32 Million Net Loss - Quiver Quantitative
InspireMD (NSPR) recall turns U.S. sales negative — and deepens quarterly loss - Stock Titan
NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance - Stocktwits
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
InspireMD (NSPR) grows revenue 56% but flags going concern and Nasdaq risk - Stock Titan
InspireMD Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set - scanx.trade
InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results - Stock Titan
Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k - webull.com
InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Approves 221,666 Restricted Shares for New Hire - Stock Titan
InspireMD Inc (NASDAQ: NSPR) Share Price, NSPR Stock News, NSPR Share Price & Updates - Kalkine
Piper Sandler Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $3 - Moomoo
InspireMD appoints Kathleen Kennedy as SVP of global sales By Investing.com - Investing.com Nigeria
Medical-device sales leader with more than 30 years returns to InspireMD - Stock Titan
InspireMD appoints Kathleen Kennedy as global sales head - scanx.trade
InspireMD, Inc. (NASDAQ: NSPR) eliminates chief commercial officer position - Stock Titan
NSPR|InspireMD Inc|Price:0.650|Chg%:-0.024 - TradingKey
InspireMD Inc (NSPR) Income Statement - TradingKey
InspireMD Inc (NSPR) Institutional Confidence - TradingKey
InspireMD Inc (NSPR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
InspireMD Inc (NSPR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InspireMD Inc (NSPR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
InspireMD Inc (NSPR) Cash Flow - TradingKey
NSPR|InspireMD Inc|Price:0.690|Chg%:+0.006 - TradingKey
InspireMD Inc. Revenue Breakdown – NASDAQ:NSPR - TradingView
InspireMD Inc. (NSPR) Q1 2026 Earnings: EPS Surpasses Estimates Despite Limited Revenue DisclosureROE Trend Analysis - dars.gov.et
InspireMD Inc (NSPR) Valuation: PE, PB & Fair Value Analysis - TradingKey
InspireMD, Inc. Receives Notice of Delisting from NASDAQ – Form 8-K Filing July 2026 - Minichart
InspireMD Receives Nasdaq Minimum Bid Price Warning - Moomoo
InspireMD Receives Nasdaq Notice on Bid Price Compliance - TipRanks
InspireMD Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
InspireMD (NSPR) warned by Nasdaq over $1.00 bid price and delisting risk - Stock Titan
InspireMD (NSPR) Narrows Near Support After a Slight PullbackThrowback Trade - dars.gov.et
InspireMD, Inc. Files Form 8-K: Company Details, Stock Info, and SEC Compliance for June 2026 - Minichart
InspireMD director Raymond W. Cohen to resign from board effective July 1, 2026 - TradingView
Board member Raymond Cohen to leave InspireMD (NSPR) effective July 1, 2026 - Stock Titan
InspireMD (NSPR) Slips 4.5% on Selling Pressure, Tests Key Support LevelPut Spread Alert - dars.gov.et
InspireMD Inc. (NSPR) Q1 2026 Earnings: EPS Beat Drives Modest Stock GainAnalyst Drop Coverage - dars.gov.et
Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $4 - Moomoo
InspireMD, Inc.(NasdaqCM: NSPR) dropped from Russell 3000E Growth Benchmark - marketscreener.com
InspireMD, Inc.(NasdaqCM:NSPR) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Price to sales forward of InspireMD Inc. – NASDAQ:NSPR - TradingView
Enterprise value to EBITDA forward of InspireMD Inc. – NASDAQ:NSPR - TradingView
Enterprise value to revenue forward of InspireMD Inc. – NASDAQ:NSPR - TradingView
Enterprise value to EBIT forward of InspireMD Inc. – NASDAQ:NSPR - TradingView
Price to earnings forward of InspireMD Inc. – NASDAQ:NSPR - TradingView
InspireMD Inc. Actuals & Estimates (NASDAQ:NSPR) - TradingView
NSPR Forecast — Price Target — Prediction for 2027 - TradingView
InspireMD Inc (NSPR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):